Can you take tirzepatide or semaglutide with ADHD medicine?
Yes, US and UK tirzepatide (Mounjaro, Zepbound) and semaglutide (Ozempic, Wegovy) labels do not bar ADHD medicine or name it as an interaction. Both drugs slow stomach emptying, which could affect oral medicines, and we found no study testing the pair. Both medicine groups can cut appetite and raise heart rate.
Do labels warn against taking ADHD medicine with a GLP-1?
US and UK tirzepatide and semaglutide labels name no ADHD medicine in their interaction sections, and we found no study of how the pair interacts.123411131415910
The US Vyvanse, Concerta, Adderall XR and Strattera labels do not list GLP-1 medicines among their drug interactions.5678 We read these four US ADHD labels for this page, and did not check guanfacine, clonidine or other ADHD medicines. No GLP-1 label we read lists ADHD medicine as a reason to avoid the drug.123411131415
A missing warning does not prove the pair is safe.
The labels flag oral medicines as a group.123 The US Zepbound label asks for caution and says to monitor oral medicines that depend on threshold levels to work.1
The UK Mounjaro SmPC (the official UK product information) says delayed effect should be considered when a rapid onset matters.3 The US Wegovy label says to monitor the effects of oral medicines.2
Could a GLP-1 change how your ADHD medicine works?
It could, because tirzepatide and semaglutide slow stomach emptying, but we found no study measuring the effect on any ADHD medicine.129
On the US Zepbound label, a first 5 mg dose cut peak paracetamol (acetaminophen) by 55%.1 The peak came 1 hour later.1 Overall exposure did not change.1
At week 6 on 15 mg, the label reports no meaningful effect on the peak or its timing.1 It says the stomach delay is largest after the first dose, then fades.1
The US Wegovy label does not say whether the delay fades.2 A 1 mg weekly semaglutide injection did not affect oral medicine absorption in its studies.2
A 2024 review of injectable GLP-1 medicines found some oral drug peaks lower or later.17 Total exposure showed no clinically significant change.17 It did not cover tirzepatide or any ADHD medicine.17
What do food studies suggest about ADHD medicine timing?
Some ADHD medicines peak later after food on their US labels, which gives a rough comparison but does not show what a GLP-1 does.578
On the US Adderall XR label, a high-fat meal delayed the amphetamine peak by about 2.5 hours, without changing total absorption.7 On the US Strattera label, food delayed the atomoxetine peak by 3 hours and lowered it by 37%.8 The US Concerta label found no difference after a high-fat breakfast.6
Lisdexamfetamine (Vyvanse, sold as Elvanse in the UK)16 is converted to its active form mainly in the blood.5 On the US Vyvanse label, a high-fat meal delayed the peak of the capsule and chewable forms by about 1 hour.5
Which side effects overlap between the two medicine groups?
Appetite loss and a faster heart rate appear on both sides, and we found no study measuring them on the pair.1259
Decreased appetite affected 27% of adults on Vyvanse, against 2% on placebo, in a US label trial.5 Concerta was 25% against 7%, Adderall XR 33% against 3%, and Strattera 16% against 3%.678
The US Zepbound and Wegovy labels say both drugs lower calorie intake, likely by affecting appetite.12 The US Vyvanse label says it is not for weight loss.5 It links other stimulant-type drugs used that way to serious heart events.5
US stimulant labels report average heart rate rises of 3 to 6 beats per minute.567 The US Zepbound label reports average heart rate rises of 1 to 3 beats per minute.1 The US Wegovy injection label reports 1 to 4.2
The US Zepbound label links dehydration from stomach side effects to kidney injury, and advises avoiding fluid loss.1
What do people on GLP-1 medicines report about ADHD medicine?
From public patient forums: 189 Reddit threads in r/Zepbound, r/mounjarouk, r/Mounjaro, r/WegovyPillWeightLoss, r/Semaglutide and r/WegovyWeightLoss, posts from October 2025 to October 2026. Personal reports, not medical evidence.
What people describe
- Not studied Several say ADHD medicine feels weaker, starts later or lasts longer. Several others notice no change, and several report needing less or stopping it. We found no study of this.
- Not studied Several say long-acting forms seem more affected, or that switching to immediate-release helped. A few say immediate-release did not help or caused new problems. We found no study comparing them.
- Matches the label Many describe very low appetite or trouble eating enough on both medicines. The labels report lower appetite or intake for each medicine alone, not the pair.15
- Matches the label Several describe a fast heart rate or palpitations on a GLP-1, with or without a stimulant, while a few report no heart rate problem. The labels report raised heart rate for each medicine alone.25
- Not studied Several say a GLP-1 brought a calmer mind or better focus. Several others report no change in ADHD, and several describe worse focus, flatness or low mood. We found no trial of GLP-1 medicines for ADHD symptoms.
Advice people share
- Not studied Several suggest an earlier stimulant dose. The US Vyvanse label says morning, avoiding afternoon doses.5 We found no study of earlier dosing on a GLP-1.
- Not studied Several suggest eating at set times or with reminders, rather than waiting for hunger. We found no study of this.
- Matches the label Several on Wegovy tablets say they take the tablet first, wait the required time, then take other medicines. The US label and UK SmPC both say to wait at least 30 minutes.211
- Label says otherwise Several describe taking a GLP-1 less often than labelled, and a few describe altering stimulants. The US Zepbound and Wegovy injection labels give once-weekly dosing. The US Concerta label says not to split, crush or chew the tablets, and the US Vyvanse label says not to divide a single dose.1256
In your country
Tirzepatide and semaglutide are the same compounds everywhere, but brand names differ and the ADHD medicine figures above come from US labels.
Australia
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill treated as not approved). Semaglutide tablets, diabetes: Rybelsus approved; whether supplied not confirmed.
Label: We could not open Australia's own label for this page. It relies on the US and UK labels named above.
Emergency number: 000
Canada
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen, Zepbound. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Semaglutide Injection (Dr. Reddy’s; shortage reported Jul 2026, lots recalled Aug 2026); Apo-Semaglutide (one lot recalled Aug 2026). Semaglutide tablets, weight: none (no oral Wegovy in Health Canada’s drug database). Semaglutide tablets, diabetes: Rybelsus. Semaglutide approved but not marketed: Sevmia, Poviztra, Plosbrio, Aspen-Semaglutide, Semaglutide Injection (Aspen), Sandoz Semaglutide.
Label: We could not find Canada's own product monographs for this page. It relies on the US and UK labels named above.
Emergency number: 911
France
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: none (Wegovy pill not sold in France). Semaglutide tablets, diabetes: none found (Rybelsus not in France’s medicines database).
Label: We could not read the EU product information for this page. It relies on the US and UK labels named above.
Emergency number: 15 or 112
Germany
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy Tablette. Semaglutide tablets, diabetes: Rybelsus.
Label: We could not read the EU product information for this page. It relies on the US and UK labels named above.
Emergency number: 112
India
Sold as: Tirzepatide: Mounjaro, Yurpeak. Semaglutide injection, weight: Wegovy; Poviztra; Noveltreat. Semaglutide injection, diabetes: Ozempic; Obeda (Dr Reddy’s; recalled Jul 2026 over an active-ingredient impurity; on 23 Oct 2026 the company said it planned to relaunch in Nov; resumption not confirmed at 8 Nov 2026; distributors told Reuters it may be discontinued); Sematrinity; GLIPIQ; Semalix (batches recalled Jul 2026); Semanat; Semafull. Semaglutide injection, diabetes and weight: Semaglyn; Mashema; Alterme; Semasize; Obesema; Hepaglide. Semaglutide, diabetes and weight (form not confirmed): Obeda Pro; Obeda Plus (Dr Reddy’s, made by Hetero Labs; in the market from late Jul 2026). Semaglutide injection, use not confirmed: Semanext; Livarise; Sundae. Semaglutide, form and use not confirmed: Samakind; Usema (batches recalled). Semaglutide tablets, weight: not confirmed. Semaglutide tablets, diabetes: Rybelsus; Sembolic; Obeda (tablets not part of the Jul 2026 recall).
Label: We did not open an Indian label for this page. It relies on the US and UK labels named above.
Emergency number: 112
Saudi Arabia
Sold as: Tirzepatide: Mounjaro, Mounjaro KwikPen. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic; Tasylev; Lugyda; Glucentra. Semaglutide tablets, weight: none (Wegovy pill not registered). Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a Saudi label for this page. It relies on the US and UK labels named above.
Emergency number: 997 or 911
United Arab Emirates
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Rybelsus.
Label: We did not open a UAE label for this page. It relies on the US and UK labels named above.
Emergency number: 998 for an ambulance, or 999
United Kingdom
Sold as: Tirzepatide: Mounjaro. Semaglutide injection, weight: Wegovy, including 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy tablets (authorised 11 Jun 2026; retail sale not confirmed). Semaglutide tablets, diabetes: Rybelsus.
Label: The UK Mounjaro SmPC expects no dose change for most oral medicines, but says delayed effect should be considered when a rapid onset matters.3 It reports a 50% fall in peak paracetamol after a first 5 mg dose, against 55% in the US Zepbound label.31 The UK Wegovy injection SmPC says no dose adjustment is needed for the oral medicines tested with semaglutide.4 The UK Ozempic SmPC says semaglutide should be used with caution alongside oral medicines that need rapid absorption from the gut.15 The US Wegovy label says to monitor the effects of oral medicines.2 None names an ADHD medicine.123415
Emergency number: 999
United States
Sold as: Tirzepatide: Zepbound, Mounjaro. Semaglutide injection, weight: Wegovy, including Wegovy HD 7.2 mg. Semaglutide injection, diabetes: Ozempic. Semaglutide tablets, weight: Wegovy pill. Semaglutide tablets, diabetes: Ozempic tablets; Rybelsus (being discontinued).
Label: The answer above applies.
Emergency number: 911
Contact your prescriber or a doctor right away if your heart races or pounds while you are resting.2
Read the full picture
Related questions
Sources
- US Zepbound (tirzepatide) prescribing information, Eli Lilly, revised August 2026.
- US Wegovy (semaglutide) injection and tablets prescribing information, Novo Nordisk, on DailyMed, revised June 2026.
- UK Mounjaro KwikPen (tirzepatide) SmPC, electronic medicines compendium, updated 8 September 2026.
- UK Wegovy FlexTouch (semaglutide) injection SmPC, electronic medicines compendium, updated 22 September 2026.
- US Vyvanse (lisdexamfetamine) prescribing information, Takeda, on DailyMed, revised April 2026.
- US Concerta (methylphenidate) prescribing information, Janssen, on DailyMed, revised April 2026.
- US Adderall XR (mixed amphetamine salts) prescribing information, on DailyMed, revised April 2026.
- US Strattera (atomoxetine) prescribing information, on DailyMed, revised June 2026.
- PubMed search for GLP-1 medicines and ADHD medicines, 126 results, all read on 8 November 2026.
- ClinicalTrials.gov search for GLP-1 medicines and ADHD, 2 results, neither on ADHD, checked 8 November 2026.
- UK Wegovy 25 mg tablets (semaglutide) SmPC, electronic medicines compendium, updated 16 June 2026.
- Recognizing medical emergencies, MedlinePlus, US National Library of Medicine, listing American College of Emergency Physicians warning signs, reviewed 8 January 2025.
- US Mounjaro (tirzepatide) prescribing information, Eli Lilly, revised August 2026.
- US Ozempic (semaglutide) injection prescribing information, Novo Nordisk, on DailyMed, revised May 2026.
- UK Ozempic (semaglutide) injection SmPC, electronic medicines compendium, updated 28 July 2026.
- UK Elvanse Adult 50 mg capsules (lisdexamfetamine) SmPC, Takeda UK, electronic medicines compendium, updated 16 October 2026.
- Calvarysky B, Dotan I, Shepshelovich D, Leader A, Cohen TD. Drug-drug interactions between glucagon-like peptide 1 receptor agonists and oral medications: a systematic review. Drug Saf. 2024;47(5):439-451.
Last checked Nov 8, 2026 · Next review due Nov 8, 2027 · Report an error
How this answer was made. Written by the GLP Guidebook team from the sources above, all checked on Nov 8, 2026. The “What people report” section summarises public patient forum posts we read; it is not medical evidence, and we never pass on advice that goes against the label. It’s general information, not medical advice. Talk to a doctor, pharmacist or other licensed prescriber before starting, stopping or changing any medicine. In an emergency, call your local emergency number. How we write